Prelude Therapeutics Inc has filed an 8-K report detailing an agreement with Jefferies LLC to offer up to $25 million of its common stock. This follows a previous agreement allowing for a total of $75 million in stock sales, enhancing liquidity for the company.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.